CHS Inc.
Get $10 bonus on your first $100 deposit for CHSCN
Get $10 bonus on your first $100 deposit for CHSCN
CHS Inc. (CHSCN) Stock Competitors & Peer Comparison
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $25.01 | +0.48% | 306.9M | N/A | N/A | +7.40% |
| ADM | $73.83 | +2.02% | 35.5B | 33.11 | $2.23 | +2.78% |
| BG | $129.42 | +0.86% | 25B | 26.25 | $4.93 | +2.16% |
| TSN | $64.63 | +0.51% | 23B | 115.41 | $0.56 | +3.13% |
| SFD | $28.37 | -0.80% | 11.2B | 11.30 | $2.51 | +3.52% |
| AGRO | $15.22 | +2.63% | 7.8B | -304.40 | -$0.05 | +2.30% |
| CALM | $78.10 | -6.31% | 3.7B | 5.43 | $14.37 | +10.13% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| FDP | $41.25 | +2.74% | 2B | 21.94 | $1.88 | +2.91% |
| DOLE | $14.56 | +2.10% | 1.4B | 14.42 | $1.01 | +2.34% |
Stock Comparison
CHSCN vs ADM Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, ADM has a market cap of 35.5B. Regarding current trading prices, CHSCN is priced at $25.01, while ADM trades at $73.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 33.11. In terms of profitability, CHSCN's ROE is +0.06%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ADM's competition here
CHSCN vs BG Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, BG has a market cap of 25B. Regarding current trading prices, CHSCN is priced at $25.01, while BG trades at $129.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 26.25. In terms of profitability, CHSCN's ROE is +0.06%, compared to BG's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check BG's competition here
CHSCN vs TSN Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, TSN has a market cap of 23B. Regarding current trading prices, CHSCN is priced at $25.01, while TSN trades at $64.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 115.41. In terms of profitability, CHSCN's ROE is +0.06%, compared to TSN's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSN's competition here
CHSCN vs SFD Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, SFD has a market cap of 11.2B. Regarding current trading prices, CHSCN is priced at $25.01, while SFD trades at $28.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 11.30. In terms of profitability, CHSCN's ROE is +0.06%, compared to SFD's ROE of +0.15%. Regarding short-term risk, CHSCN is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SFD's competition here
CHSCN vs AGRO Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AGRO has a market cap of 7.8B. Regarding current trading prices, CHSCN is priced at $25.01, while AGRO trades at $15.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is -304.40. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRO's ROE of -0.01%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRO's competition here
CHSCN vs CALM Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, CALM has a market cap of 3.7B. Regarding current trading prices, CHSCN is priced at $25.01, while CALM trades at $78.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 5.43. In terms of profitability, CHSCN's ROE is +0.06%, compared to CALM's ROE of +0.26%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CALM's competition here
CHSCN vs IBA Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $25.01, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.06%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check IBA's competition here
CHSCN vs FDP Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, FDP has a market cap of 2B. Regarding current trading prices, CHSCN is priced at $25.01, while FDP trades at $41.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 21.94. In terms of profitability, CHSCN's ROE is +0.06%, compared to FDP's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check FDP's competition here
CHSCN vs DOLE Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, DOLE has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $25.01, while DOLE trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 14.42. In terms of profitability, CHSCN's ROE is +0.06%, compared to DOLE's ROE of +0.04%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DOLE's competition here
CHSCN vs VITL Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, VITL has a market cap of 564M. Regarding current trading prices, CHSCN is priced at $25.01, while VITL trades at $12.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 8.74. In terms of profitability, CHSCN's ROE is +0.06%, compared to VITL's ROE of +0.21%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VITL's competition here
CHSCN vs LND Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, LND has a market cap of 408.4M. Regarding current trading prices, CHSCN is priced at $25.01, while LND trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is 15.19. In terms of profitability, CHSCN's ROE is +0.06%, compared to LND's ROE of -0.04%. Regarding short-term risk, CHSCN is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LND's competition here
CHSCN vs CHSCP Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, CHSCP has a market cap of 338M. Regarding current trading prices, CHSCN is priced at $25.01, while CHSCP trades at $27.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCP's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to CHSCP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCP's competition here
CHSCN vs ALCO Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, ALCO has a market cap of 322.8M. Regarding current trading prices, CHSCN is priced at $25.01, while ALCO trades at $42.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -2.27. In terms of profitability, CHSCN's ROE is +0.06%, compared to ALCO's ROE of -1.27%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ALCO's competition here
CHSCN vs CHSCO Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, CHSCO has a market cap of 319.7M. Regarding current trading prices, CHSCN is priced at $25.01, while CHSCO trades at $26.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCO's ROE of +0.06%. Regarding short-term risk, CHSCN is more volatile compared to CHSCO. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCO's competition here
CHSCN vs VFF Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, VFF has a market cap of 315.4M. Regarding current trading prices, CHSCN is priced at $25.01, while VFF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 15.22. In terms of profitability, CHSCN's ROE is +0.06%, compared to VFF's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VFF's competition here
CHSCN vs CHSCL Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, CHSCL has a market cap of 311M. Regarding current trading prices, CHSCN is priced at $25.01, while CHSCL trades at $25.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCL's ROE of +0.06%. Regarding short-term risk, CHSCN is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCL's competition here
CHSCN vs CHSCM Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, CHSCM has a market cap of 300.8M. Regarding current trading prices, CHSCN is priced at $25.01, while CHSCM trades at $24.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCM's ROE of +0.06%. Regarding short-term risk, CHSCN is more volatile compared to CHSCM. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCM's competition here
CHSCN vs AFRI Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AFRI has a market cap of 263.1M. Regarding current trading prices, CHSCN is priced at $25.01, while AFRI trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -12.54. In terms of profitability, CHSCN's ROE is +0.06%, compared to AFRI's ROE of -2.30%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRI's competition here
CHSCN vs LMNR Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, LMNR has a market cap of 235.6M. Regarding current trading prices, CHSCN is priced at $25.01, while LMNR trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -10.16. In terms of profitability, CHSCN's ROE is +0.06%, compared to LMNR's ROE of -0.13%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LMNR's competition here
CHSCN vs AGFS Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $25.01, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is more volatile compared to AGFS. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AGFS's competition here
CHSCN vs LOCL Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, LOCL has a market cap of 36.5M. Regarding current trading prices, CHSCN is priced at $25.01, while LOCL trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.29. In terms of profitability, CHSCN's ROE is +0.06%, compared to LOCL's ROE of +0.66%. Regarding short-term risk, CHSCN is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL's competition here
CHSCN vs PME Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $25.01, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.06%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check PME's competition here
CHSCN vs AFRIW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AFRIW has a market cap of 20.2M. Regarding current trading prices, CHSCN is priced at $25.01, while AFRIW trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -32.61. In terms of profitability, CHSCN's ROE is +0.06%, compared to AFRIW's ROE of -2.30%. Regarding short-term risk, CHSCN is less volatile compared to AFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRIW's competition here
CHSCN vs APPHW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.01, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPHW's competition here
CHSCN vs APPH Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.01, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.06%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPH's competition here
CHSCN vs EDBLW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, EDBLW has a market cap of 4.3M. Regarding current trading prices, CHSCN is priced at $25.01, while EDBLW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.07. In terms of profitability, CHSCN's ROE is +0.06%, compared to EDBLW's ROE of -3.08%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBLW's competition here
CHSCN vs AQB Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AQB has a market cap of 3.4M. Regarding current trading prices, CHSCN is priced at $25.01, while AQB trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -1.54. In terms of profitability, CHSCN's ROE is +0.06%, compared to AQB's ROE of +40.02%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AQB's competition here
CHSCN vs KALWW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.01, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KALWW's competition here
CHSCN vs KAL Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.01, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KAL's competition here
CHSCN vs AGRI Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AGRI has a market cap of 1.9M. Regarding current trading prices, CHSCN is priced at $25.01, while AGRI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is 0.00. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRI's ROE of -0.63%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRI's competition here
CHSCN vs SDOT Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, SDOT has a market cap of 1.5M. Regarding current trading prices, CHSCN is priced at $25.01, while SDOT trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is -0.08. In terms of profitability, CHSCN's ROE is +0.06%, compared to SDOT's ROE of -0.46%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SDOT's competition here
CHSCN vs AVX Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AVX has a market cap of 1.5M. Regarding current trading prices, CHSCN is priced at $25.01, while AVX trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AVX's ROE of -0.63%. Regarding short-term risk, CHSCN is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AVX's competition here
CHSCN vs EDBL Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, EDBL has a market cap of 295.4K. Regarding current trading prices, CHSCN is priced at $25.01, while EDBL trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to EDBL's ROE of -3.08%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBL's competition here
CHSCN vs AAGR Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AAGR has a market cap of 289.3K. Regarding current trading prices, CHSCN is priced at $25.01, while AAGR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to AAGR's ROE of +3.27%. Regarding short-term risk, CHSCN is more volatile compared to AAGR. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AAGR's competition here
CHSCN vs SANW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, SANW has a market cap of 236.1K. Regarding current trading prices, CHSCN is priced at $25.01, while SANW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SANW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to SANW's ROE of -0.11%. Regarding short-term risk, CHSCN is less volatile compared to SANW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SANW's competition here
CHSCN vs AGRIW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCN is priced at $25.01, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRIW's ROE of -0.63%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRIW's competition here
CHSCN vs AAGRW Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCN is priced at $25.01, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGRW's competition here
CHSCN vs DTCK Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, DTCK has a market cap of 7.6K. Regarding current trading prices, CHSCN is priced at $25.01, while DTCK trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -0.66. In terms of profitability, CHSCN's ROE is +0.06%, compared to DTCK's ROE of -0.60%. Regarding short-term risk, CHSCN is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DTCK's competition here
CHSCN vs OME Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, OME has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.01, while OME trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas OME's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to OME's ROE of +0.10%. Regarding short-term risk, CHSCN is more volatile compared to OME. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check OME's competition here
CHSCN vs LOCL-WT Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, LOCL-WT has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.01, while LOCL-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL-WT's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to LOCL-WT's ROE of +0.66%. Regarding short-term risk, CHSCN is less volatile compared to LOCL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL-WT's competition here
CHSCN vs TSNU Comparison April 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 306.9M. In comparison, TSNU has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.01, while TSNU trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSNU's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to TSNU's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to TSNU. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSNU's competition here